The organ that turned out to be a side door
Chickens (Gallus gallus domesticus) have an organ humans and other mammals simply don’t: the bursa of Fabricius, a pouch near the tail end of the gut. It was identified as the birthplace of B cells, the white blood cells that produce antibodies, so long ago that “bursa-dependent” became textbook shorthand for that whole branch of the immune system. For more than 50 years, the assumption held without much challenge: if a chicken had a B cell, it came from the bursa. Full stop.
On July 15, 2026, Ryota Hirakawa and Tomonori Nochi of Tohoku University’s Graduate School of Agricultural Science published evidence in the Proceedings of the National Academy of Sciences that a second population of B cells exists, one that never passes through the bursa at all. Same species, same immune job, a completely different route to get there.
Bone marrow to gut, no detour
B-cell progenitors are supposed to travel from the bone marrow to the bursa to finish developing. Hirakawa and Nochi found a subset that skips that stop. These cells carry a receptor called CXCR4 and follow a chemical signal, CXCL12, straight to the cecal tonsils, patches of immune tissue tucked along the chicken’s gut near the ceca. Once there, they pick up surface IgM and convert into plasma cells, the antibody factories of the immune system, churning out immunoglobulin A, or IgA, the antibody class that patrols mucosal surfaces like the gut lining. The paper also notes that the bursa itself starts shrinking after hatching, which fits: something else has to be picking up the slack, and this bursa-independent route appears to become the dominant source of gut B cells after a chicken hatches.
Why two routes beat one
Anatomy alone doesn’t tell you why a second pathway would matter. The experiment does. In a single combined test, Hirakawa and Nochi blocked both routes at once: the flow of CXCR4-carrying cells from the bone marrow, and the traditional bursa pathway. With both shut down, IgA production in the gut stopped entirely. Without it, a normally minor resident of the chicken gut, the bacterium Streptococcus alactolyticus, overgrew, breached the intestinal wall, and turned up in the liver, triggering inflammation and disrupting normal liver metabolism. When the researchers gave the affected chickens a fecal preparation enriched with IgA from healthy birds, those problems reversed.
That result puts real stakes behind the anatomy. The two B-cell pathways aren’t doing the same job twice out of biological redundancy. They’re running a joint operation, and losing either one lets the gut’s bacterial population tip out of balance and threaten an organ, the liver, that has nothing to do with digesting the microbes in question.
Fifty years of one rule
The myth here is specific, not vague: for over five decades, the bursa of Fabricius was treated as the sole site of B-cell development in birds, a foundational claim of avian immunology since the organ’s discovery. This study doesn’t soften that claim. It overturns it, with a documented, independent developmental route, from bone marrow straight to gut tissue, that produces functional, antibody-secreting B cells without the bursa ever entering the picture.
What decides which road a B cell takes
What the paper does not answer is what tells a developing B cell which road to take, bursa-bound or straight to the gut. Hirakawa and Nochi establish that both routes exist and that they cooperate to hold the gut-liver balance in place, but the switch that forks the path is still unidentified. The researchers name this as their next target, along with the broader question of whether the CXCL12/CXCR4 signaling seen here, and a related CXCL13/CXCR5 pathway tied to the bursa route, actually govern B-cell development across a chicken’s whole lifespan, or just part of it.
It’s an open question with an obvious appeal to anyone raising poultry at scale: understanding the switch could eventually mean boosting gut IgA without reaching for antibiotics. That application doesn’t exist yet. What exists is a fifty-year-old textbook fact with a hole in it, and a study that found the hole by tracing where the antibodies actually came from.